Science Letter
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Science Letter
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reaction
Adverse effects are associated with bone morphogenetic protein-2 use
April 21st, 2006
According to recently published research from the United States, adverse effects are associated with high-dose recombinant human bone morphogenetic protein-2 (rhBMP-2) use in anterior cervical spine fusion. L.B.E. Shields and colleagues, University of Louisville, wrote that the study was undertaken as "a retrospective review of patients who underwent an anterior cervical fusion using rhBMP-2 with an absorbable collagen sponge (INFUSE; Medtronic Sofamor Danek, Minneapolis, MN)." They added, "To ascertain the complication rate after the use of high-dose INFUSE in anterior cervical fusions. The rhBMP-2 has been primarily investigated in lumbar spine...
Source: Science Letter (2006-04-21)
|
